Coronavirus vaccine trials: Bharat Biotech said that it is steadily moving towards its goal of 26,000 volunteers. Phase 3 of human clinical trials for Covaxin began in mid-November

COVID-19 vaccine: The ministry added that the doctor has a history of allergic reactions and said that there is no evidence from clinical trials that anyone has developed an inflammation of the brain after the vaccine's application

The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter

Coronavirus vaccine in India: Talking about the vaccine, the minister urged people not to pay heed to any rumours. He said India became free of polio disease because of the vaccine

The number of people who have recuperated from the disease surged to 99,06,387, pushing the national recovery rate to 96.12 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent

Coronavirus vaccination drive: The task force has added 31 COVID-19 vaccine hubs that will supply vaccines to 29,000 vaccination points

A sample number of beneficiaries will undergo a mock immunisation process. Staff of vaccination centres, a select group of healthcare workers will participate in the mock immunisation drive

Covishield has become the first coronavirus vaccine to receive a regulatory nod in India. Now, Drug Controller General of India (DCGI) will take a final call on rolling out the inoculation

The stations from where commuters cannot exit are Central Secretariat and Khan Market on the Violet line, Pragati Maidan (now called Supreme Court), and Mandi House on the Blue line

Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves

Earlier only four states - Andhra Pradesh, Gujarat, Punjab and Assam, had carried out a two-day dry run to review the readiness of the mechanism laid out for the COVID-19 immunisation drive

The number of people who have recuperated from the disease surged to 98,60,280 pushing the national recovery rate to 96.04 percent, while the COVID-19 case fatality rate stands at 1.45 percent

US Vice President-elect Kamala Harris received a COVID-19 vaccine shot on Tuesday, as the incoming Joe Biden administration seeks to boost confidence in the inoculation. Argentina, on the other hand, has shown  a green light for the emergency use of the Russian vaccine, Sputnik V, with Ireland beginning the mass vaccination drive for the Pfizer-BioNTech vaccine. Watch the video for more.

The result is based on interim analysis of data from its Phase III clinical trial

The woman managed to board a Vishakhapatnam-bound special train along with her son from New Delhi after having tested COVID-19 positive on December 22

Realme Watch S Pro comes with a blood oxygen level monitor that is perhaps an important tool to have on your smartwatch these days.

Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds

The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"

Twenty-year-old pilot Samy Kramer flew his Diamond DA20 Katana light aircraft for 200km in a route laid out in the likeness of a syringe to celebrate the beginning of vaccination drive in Europe

The MoU has been signed with Pluss Advanced Technologies (PLUSS) for the supply of indigenously developed precise temperature control boxes